RCUS
Arcus Biosciences Inc
NYSE: RCUS · HEALTHCARE · BIOTECHNOLOGY
$24.13
-2.70% today
Updated 2026-04-29
Market cap
$3.03B
P/E ratio
—
P/S ratio
12.27x
EPS (TTM)
$-3.29
Dividend yield
—
52W range
$7 – $29
Volume
1.3M
Arcus Biosciences Inc (RCUS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+24.3%
Last 4 quarters
Revenue YoY growth
+26.9%
Most recent quarter
EPS YoY growth
+13.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.0%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+9.1%
2025-10-28
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $-0.89 | +19.1% | $20.19 | $19.54 | -3.2% |
| 2025-10-28 | $-1.27 | +0.8% | $18.60 | $20.29 | +9.1% |
| 2025-08-06 | $0.00 | +100.0% | $9.55 | $9.28 | -2.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.10 | $-0.89 | +19.1% | $33.00M | +26.9% |
| 2025-09-30 | $-1.28 | $-1.27 | +0.8% | $26.00M | -45.8% |
| 2025-06-30 | $-1.12 | $0.00 | +100.0% | $160.00M | +310.3% |
| 2025-03-31 | $-0.93 | $-1.14 | -22.6% | $28.00M | -80.7% |
| 2024-12-31 | $-1.20 | $-1.03 | +14.4% | $26.00M | -16.1% |
| 2024-09-30 | $-1.06 | $-1.00 | +5.7% | $48.00M | +50.0% |
| 2024-06-30 | $-1.10 | $-1.02 | +7.3% | $39.00M | +34.5% |
| 2024-03-31 | $-0.95 | $-0.05 | +94.7% | $145.00M | — |
| 2023-12-31 | $-1.02 | $-1.08 | -5.9% | $31.00M | — |
| 2023-09-30 | $-1.13 | $-0.94 | +16.8% | $32.00M | — |
| 2023-06-30 | $-1.10 | $-1.04 | +5.5% | $29.00M | — |
Frequently asked questions
Has Arcus Biosciences Inc beaten earnings estimates?
Arcus Biosciences Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +24.3% over the last 4 quarters.
How does RCUS stock react to earnings?
RCUS stock has moved an average of +1.0% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Arcus Biosciences Inc's revenue growth rate?
Arcus Biosciences Inc reported year-over-year revenue growth of +26.9% in its most recent quarter, with EPS growing +13.6% year-over-year.